Topic resource collection
Approved comparison material connected to this topic.
6 resourcesRead both sides
Honesty about the evidence base matters here. The peptide is widely discussed in CIRS, mold-illness, mast-cell-activation, and post-viral communities. Not all of those discussions are anchored to published evidence. Where communi…
Shoemaker 2011 Case Series Pre-post observational 209 CIRS patients 73% showed biomarker normalisation; VCS improved 1.8 steps mean No placebo control, no independent replication, VIP not isolated from prior interventions Shoemak…
Understanding VIP's half-life in context requires comparison to other commonly researched peptides with varying stability profiles. VIP (vasoactive intestinal peptide) 1–2 minutes DPP-IV and NEP cleavage at N-terminus and interna…
Unreconstituted lyophilised VIP peptide stored at −20°C is the most stable form for transport and tolerates brief ambient exposure during transfer between freezers. Lyophilisation (freeze-drying) removes water molecules that woul…
VIP Up to 25°C for 12–18 hours max 28 days refrigerated Yes. 2–8°C pharmaceutical-grade for reconstituted Research biologic, not controlled High thermal sensitivity. Requires strict cold chain for reconstituted form BPC-157 Up to…
Collagen-Induced Arthritis (Rheumatoid Model) Intraperitoneal injection, 5–25 nmol per dose Treg expansion, TNF-alpha/IL-6 suppression, reduced synovial inflammation 60–70% reduction in arthritis clinical score vs vehicle control…